semaglutide before colonoscopy 2-Day MiraLAX® semaglutide and colonoscopy Ulcerative Colitis:

Common side effects shared by both medications: Nausea (most common, usually transient peaks during dose escalation) Vomiting Diarrhea or constipation Decreased appetite and early satiety Bloating or stomach discomfort Injection site reactions Key safety warnings that apply to both drugs: FDA Boxed Warning (both): Possible risk of thyroid C-cell tumors, based on animal studies

This filler is formulated with a thicker consistency to add structure and lift to the cheeks to restore their natural contours

Discussion This study provides new insights into the evolving role of GLP-1 RAs in healthcare, particularly how their use amongst people with overweight or obesity coincides with first-time diagnoses of type 2 diabetes, sleep apnea, and cardiovascular disease

The supplemented group showed decreased respiratory quotient, increased fat oxidation percentage, reduced insulin levels, improved insulin sensitivity (HOMA index), reduced waist circumference, and increased resting energy expenditure compared to placebo